GlaxoSmithKline Pharmaceuticals Limited vs SHILPA MEDICARE LIMITED | ESG Comparison

India ESG compliance registry and ingestion monitor

GlaxoSmithKline Pharmaceuticals Limited vs SHILPA MEDICARE LIMITED Comparison

Auto-matched BRSR ESG metric keys across selected companies.

Selected: 2 | Showing 250 rows
Filter

Keys

314

common across selection

Keys

762

total union

Mode

Year: 2025

Common keys

KPI GlaxoSmithKline Pharmaceuticals Limited SHILPA MEDICARE LIMITED Delta
Environmental Emissions
Does The Entity Have Any Project Related To Reducing Green House Gas Emission
Yes Yes -
Environmental Emissions
Indicate If Any Independent Assessment Or Evaluation Or Assurance Has Been Carried Out By An External Agency For Air Emissions Other Than GHGEmissions
Yes Yes -
Environmental Emissions diff
Total Scope 1 And Scope 2 Emissions Intensity In Term Of Physical Output
2.84 MtCO2e 186.05 MtCO2e +183.21 MtCO2e (+6451.1%)
Environmental Emissions
Total Scope 1 And Scope 2 Emissions Intensity Per Rupee Of Turnover
0 MtCO2e 0 MtCO2e +0 MtCO2e (+533.3%)
Environmental Emissions
Total Scope 1 And Scope 2 Emissions Intensity Per Rupee Of Turnover Adjusted For Purchasing Power Parity
0 MtCO2e 0 MtCO2e +0 MtCO2e (+566.7%)
Environmental Emissions diff
Total Scope 1 Emissions
1,002.89 MtCO2e 1,062.6 MtCO2e +59.71 MtCO2e (+6%)
Environmental Emissions diff
Total Scope 2 Emissions
941,911 MtCO2e 6,665.37 MtCO2e -935245.63 MtCO2e (-99.3%)
Environmental Emissions diff
Any Indicate If Any Independent Assessment Or Evaluation Or Assurance Has Been Carried Out By An External Agency For Green House Gas Emissions
Yes No -
Environmental Emissions
Air Emissions Other Than Ghg Emissions By The Entity Applicability
Yes Yes -
Environmental Emissions
Green House Gas Emissions And Its Intensity Applicability
Yes Yes -
Environmental Emissions
Total Scope 3 Emissions And Its Intensity Applicability
No No -
Environmental Energy
Energy Consumption Through Other Sources From Non Renewable Sources
0 GJ 0 GJ 0 GJ
Environmental Energy
Energy Consumption Through Other Sources From Renewable Sources
0 GJ 0 GJ 0 GJ
Environmental Energy diff
Energy Intensity In Term Of Physical Output
29.49 GJ 1,122.69 GJ +1093.2 GJ (+3707%)
Environmental Energy
Energy Intensity Per Rupee Of Turnover
0 GJ 0 GJ +0 GJ
Environmental Energy
Energy Intensity Per Rupee Of Turnover Adjusting For Purchasing Power Parity
0 GJ 0 GJ +0 GJ (+316.7%)
Environmental Energy diff
Total Electricity Consumption From Non Renewable Sources
46,642 GJ 33,005.97 GJ -13636.03 GJ (-29.2%)
Environmental Energy diff
Total Electricity Consumption From Renewable Sources
6,973 GJ 0 GJ -6973 GJ (-100%)
Environmental Energy diff
Total Energy Consumed From Non Renewable Sources
55,479 GJ 46,632.14 GJ -8846.86 GJ (-15.9%)
Environmental Energy diff
Total Energy Consumed From Renewable And Non Renewable Sources
108,022 GJ 46,632.14 GJ -61389.86 GJ (-56.8%)
Environmental Energy diff
Total Energy Consumed From Renewable Sources
52,543 GJ 0 GJ -52543 GJ (-100%)
Environmental Energy diff
Any Independent Assessment Or Evaluation Or Assurance Has Been Carried Out By An External Agency For Energy Consumption Under Leadership Indicators
Yes No -
Environmental Energy
Total Energy Consumption And Energy Intensity Applicable To The Company
Yes Yes -
Environmental Other
Recycled
0 t 0 t 0 t
Environmental Other
Battery Waste
0 t 0 t 0 t
Environmental Other diff
Bio Medical Waste
1.53 t 0 t -1.53 t (-100%)
Environmental Other diff
Construction And Demolition Waste
52.52 t 0 t -52.52 t (-100%)
Environmental Other diff
EWaste
3.39 t 204 t +200.61 t (+5917.7%)
Environmental Other diff
Has The Entity Implemented Mechanism For Zero Liquid Discharge
Yes No -
Environmental Other
Hazardous Air Pollutants
0 mg 0 mg 0 mg
Environmental Other diff
Other Hazardous Waste
132.11 t 53.84 t -78.27 t (-59.2%)
Environmental Other diff
Other Non Hazardous Waste Generated
285.89 t 0 t -285.89 t (-100%)
Environmental Other
Persistent Organic Pollutants
0 mg 0 mg 0 mg
Environmental Other diff
Plastic Waste
32.83 t 1.49 t -31.35 t (-95.5%)
Environmental Other
Radioactive Waste
0 t 0 t 0 t
Environmental Other
Recycling And/Or Safe Disposal As % To Total Turnover
0 0 0
Environmental Other diff
Total Fuel Consumption From Non Renewable Sources
8,837 GJ 13,626.17 GJ +4789.17 GJ (+54.2%)
Environmental Other diff
Total Fuel Consumption From Renewable Sources
45,570 GJ 0 GJ -45570 GJ (-100%)
Environmental Other diff
Total Waste Disposed
185.47 t 53.81 t -131.66 t (-71%)
Environmental Other diff
Total Waste Generated
508.27 t 259.32 t -248.95 t (-49%)
Environmental Other diff
Total Waste Recovered
322.8 t 204.04 t -118.76 t (-36.8%)
Environmental Other diff
Waste Disposed By Incineration
132.95 t 7.94 t -125.01 t (-94%)
Environmental Other diff
Waste Disposed By Landfilling
52.52 t 45.87 t -6.65 t (-12.7%)
Environmental Other
Waste Disposed By Other Disposal Operations
0 t 0 t 0 t
Environmental Other diff
Waste Intensity In Term Of Physical Output
0.13 t 6.24 t +6.11 t (+4700%)
Environmental Other
Waste Intensity Per Rupee Of Turnover
0 t 0 t +0 t
Environmental Other
Waste Intensity Per Rupee Of Turnover Adjusting For Purchasing Power Parity
0 t 0 t +0 t
Environmental Other
Waste Intensity The Relevant Metric May Be Selected By The Entity
0 t 0 t 0 t
Environmental Other
Waste Recovered Through Other Recovery Operations
0 t 0 t 0 t
Environmental Other
Waste Recovered Through Re Used
0 t 0 t 0 t
Environmental Other diff
Waste Recovered Through Recycled
322.8 t 204.04 t -118.76 t (-36.8%)
Environmental Other
Processes For Workers To Report The Work Related Hazards And To Remove Themselves From Such Risks
Yes Yes -
Environmental Water diff
External assurance on water withdrawal (Yes/No)
Yes No -
Environmental Water diff
Total Volume Of Water Consumption
76,714 kL 59,358 kL -17356 kL (-22.6%)
Environmental Water diff
Total Volume Of Water Withdrawal
78,057 kL 60,290 kL -17767 kL (-22.8%)
Environmental Water diff
Total Water Discharged In Kilolitres
1,343 kL 15,213 kL +13870 kL (+1032.8%)
Environmental Water diff
Water Discharge By Sent To Third Parties
0 kL 15,000 kL +15000 kL
Environmental Water diff
Water Discharge By Sent To Third Parties With Treatment
0 kL 14,409 kL +14409 kL
Environmental Water diff
Water Discharge By Sent To Third Parties Without Treatment
0 kL 591 kL +591 kL
Environmental Water diff
Water Discharge To Others
0 kL 213 kL +213 kL
Environmental Water
Water Discharge To Others With Treatment
0 kL 0 kL 0 kL
Environmental Water diff
Water Discharge To Others Without Treatment
0 kL 213 kL +213 kL
Environmental Water
Water Discharge To Seawater
0 kL 0 kL 0 kL
Environmental Water
Water Discharge To Seawater With Out Treatment
0 kL 0 kL 0 kL
Environmental Water
Water Discharge To Seawater With Treatment
0 kL 0 kL 0 kL
Environmental Water diff
Water Intensity In Term Of Physical Output
20.94 kL 0 kL -20.94 kL (-100%)
Environmental Water
Water Intensity Per Rupee Of Turnover
0 kL 0 kL +0 kL
Environmental Water
Water Intensity Per Rupee Of Turnover Adjusting For Purchasing Power Parity
0 kL 0 kL 0 kL (-67.4%)
Environmental Water diff
Water Withdrawal By Groundwater
0 kL 58,707 kL +58707 kL
Environmental Water
Water Withdrawal By Others
0 kL 0 kL 0 kL
Environmental Water
Water Withdrawal By Seawater Or Desalinated Water
0 kL 0 kL 0 kL
Environmental Water diff
Water Withdrawal By Surface Water
1,983 kL 1,370 kL -613 kL (-30.9%)
Environmental Water diff
Water Withdrawal By Third Party Water
76,074 kL 213 kL -75861 kL (-99.7%)
Environmental Water
Water discharge to groundwater
0 kL 0 kL 0 kL
Environmental Water
Water discharge to groundwater (treated)
0 kL 0 kL 0 kL
Environmental Water
Water discharge to groundwater (untreated)
0 kL 0 kL 0 kL
Environmental Water diff
Water discharge to surface water
1,343 kL 0 kL -1343 kL (-100%)
Environmental Water diff
Water discharge to surface water (treated)
1,343 kL 0 kL -1343 kL (-100%)
Environmental Water
Water discharge to surface water (untreated)
0 kL 0 kL 0 kL
Environmental Water diff
Any Independent Assessment Or Evaluation Or Assurance Has Been Carried Out By An External Agency For Water Discharged
Yes No -
Governance Governance diff
Complaints On POSHUp Held
1 0 -1 (-100%)
Governance Governance
Complaints on directors conflict of interest (count)
0 0 0
Governance Governance
Consumer Complaints Pending Resolution At End Of Year
0 0 0
Governance Governance
Consumer Complaints Received Year
0 0 0
Governance Governance diff
Specified Committee Of The Board Or Director Responsible For Decision Making On Sustainability Related Issues
Yes, your Company’s Risk Management committee has been provided with the mandate of overseeing all issues with respect to sustainability and Environment, Social... Mr. Vishnukant C Bhutada, Managing Director -
Governance Governance
Directors with disciplinary actions (count)
0 0 0
Governance Governance diff
Does The Entity Have ASpecified Committee Of The Board Or Director Responsible For Decision Making On Sustainability Related Issues
Yes No -
Governance Governance
Employees with disciplinary actions (count)
0 0 0
Governance Governance
KMPs with disciplinary actions (count)
0 0 0
Governance Governance
Median Of Remuneration Or Salary Or Wages Of Board Of Directors
₹ 0 ₹ 0 INR 0
Governance Governance
Median Of Remuneration Or Salary Or Wages Of Employees Other Than Bod And KMP
₹ 0 ₹ 0 INR 0
Governance Governance
# Board Of Directors For Remuneration Or Salary Or Wages
0 0 0
Governance Governance
# Complaints Filed Year
0 0 0
Governance Governance
# Complaints Filed From Stake Holder Group Year
0 0 0
Governance Governance
# Complaints Pending From Stake Holder Group Resolution At The End Of Year
0 0 0
Governance Governance
# Complaints Pending Resolution At The End Of Year
0 0 0
Governance Governance
# Complaints Received In Relation To Issues Of Conflict Of Interest Of The KMPs
0 0 0
Governance Governance
# Employees Other Than Bod And KMPFor Remuneration Or Salary Or Wages
0 0 0
Governance Governance
# Female Board Of Directors
2 2 0 (0%)
Governance Governance diff
% Female Board Of Directors
0.25 0.22 -0.03 (-11.1%)
Governance Governance diff
Remark For Consumer Complaints
Nil 0 -
Governance Governance
Remarks In Case Complaints Received In Relation To Issues Of Conflict Of Interest Of The Kmps
0 0 0
Governance Governance diff
Remarks Stake Holder Group From Whom Complaint Is Received
Nil NA -
Governance Governance
Remarks on directors conflict of interest complaints
0 0 0
Governance Governance diff
Total Complaints Reported Under Sexual Harassment Of Women At Workplace
2 0 -2 (-100%)
Governance Governance diff
Total # Board Of Directors
8 9 +1 (+12.5%)
Governance Governance
Workers with disciplinary actions (count)
0 0 0
Governance Other diff
Compliance With Statutory Requirements Of Relevance To The Principles And Rectification Of Any Non Compliances Frequency
Annually Quarterly -
Governance Other diff
Compliance With Statutory Requirements Of Relevance To The Principles And Rectification Of Any Non Compliances Indicate Whether Review Was Undertaken By
Any other Committee Director -
Governance Other diff
Any Corrective Action Taken Or Underway On Issues Related To Fines Or Penalties Or Action Taken By Regulators Or Law Enforcement Agencies Or Judicial Institutions On Cases Of Corruption And C~19 c 7 f 5 b 3
Since your Company is compliant, there was no corrective action taken or underway for FY 2024-25. No fines / penalties / actions are taken against the company or its employees by any regulators on corruption and conflict of interest. -
Governance Other diff
Any Corrective Actions Taken Or Underway On Issues Relating To Advertising And Delivery Of Essential Services Or Cyber Security And Data Privacy Or Recalls Or Penalty Or Action Taken By Regul~5861 bc 5 c
Since your company is compliant, there was no corrective action suggested by an auditing or inspecting authority for FY 2024-25. For FY 2024-25, there were no complaints received for issues pertaining to delivery of essential services, advertising action taken by regulatory authorities on... -
Governance Other diff
Impact Of Data Breaches
Nil Not Applicable -
Governance Other diff
Does The Entity Have AFramework Or Policy On Cyber Security And Risks Related To Data Privacy
Yes No -
Governance Other
Does The Entity Have An Anti Corruption Or Anti Bribery Policy
Yes Yes -
Governance Other
Does The Entity Have Processes In Place To Avoid Or Manage Conflict Of Interests Involving Members Of The Board
Yes Yes -
Governance Other diff
Grievance Redressal Mechanism In Place
Yes No -
Governance Other
Has The Policy Been Approved By The Board
Yes Yes -
Governance Other
Is There Mechanism Available To Receive And Redress Grievances For Other Than Permanent Employees
Yes Yes -
Governance Other
Is There Mechanism Available To Receive And Redress Grievances For Other Than Permanent Workers
Yes Yes -
Governance Other
Is There Mechanism Available To Receive And Redress Grievances For Permanent Employees
Yes Yes -
Governance Other
Is There Mechanism Available To Receive And Redress Grievances For Permanent Workers
Yes Yes -
Governance Other
Is There Mechanism Available To Receive And Redress Grievances For The Following Categories Of Employees And Worker
Yes Yes -
Governance Other
# Instances Of Data Breaches Along With Impact
0 0 0
Governance Other
% Data Breaches Involving Personally Identifiable Information Of Customers
0 0 0
Governance Other diff
Web Link At Anti Corruption Or Anti Bribery Policy Is Place
https://india-pharma.gsk.com/media/6802/anti-bribery-and-corruption-policy-v15.pdf https://www.themismedicare.com/uploads/statutory/pdf/business-code-of-conduct--ethics-23.pdf -
Governance Other diff
Web Link For Grievance Redress Policy
www.gsk.com https://www.themismedicare.com/ -
Governance Other diff
Web Link Of The Policy On Cyber Security And Risks Related To Data Privacy
https://privacy.gsk.com/en-in/privacy-notice/general/ www.vbshilpa.com -
Governance Other diff
Any Independent Assessment Or Evaluation Or Assurance Has Been Carried Out By An External Agency For Waste Management
Yes No -
Governance Other diff
Company Has Undertaken Assessment Or Assurance Of The BRSRCore
Yes assurance No -
Governance Other
Waste Collection Plan Is In Line With The Extended Producer Responsibility Plan Submitted To Pollution Control Boards
Yes Yes -
Other Other diff
Address Of Corporate Office
GlaxoSmithKline Pharmaceuticals Limited, GSK House, Worli, Dr Annie Besant Road, Mumbai- 400030 11/12 Udyog Nagar, S.V Road, Goregaon West, Mumbai - 400 104. -
Other Other diff
Address Of Registered Office
GlaxoSmithKline Pharmaceuticals Limited, GSK House, Worli, Dr Annie Besant Road, Mumbai- 400030 Plot No 69-A, GIDC Industrial Estate, Vapi - 396 195, Dist- Valsad, Gujarat. -
Other Other diff
Accounts Payable Year
₹ 46,720 ₹ 137 INR -46583 (-99.7%)
Other Other diff
Cost Incurred On Well Being Measures
₹ 0.48 ₹ 10,830,000 INR +10829999.52 (+2256249900%)
Other Other diff
Investments In Related Parties
₹ 1 ₹ 10,475,432,000 INR +10475431999 (+1047543199900%)
Other Other diff
Loans And Advances Given To Related Parties
₹ 100 ₹ 5,041,503,000 INR +5041502900 (+5041502900%)
Other Other diff
Purchases From Related Parties
₹ 32 ₹ 1,450,003,000 INR +1450002968 (+4531259275%)
Other Other
Purchases From Top Ten Trading Houses
₹ 0 ₹ 0 INR 0
Other Other
Purchases From Trading Houses
₹ 0 ₹ 0 INR 0
Other Other
Re Used
0 t 0 t 0 t
Other Other
Safely Disposed
0 t 0 t 0 t
Other Other diff
Sales To Dealers Or Distributors
₹ 99 ₹ 203,715,150 INR +203715051 (+205772778.8%)
Other Other diff
Sales To Related Parties
₹ 0 ₹ 84,121,000 INR +84121000
Other Other diff
Sales To Top Ten Dealers Or Distributors
₹ 10.85 ₹ 86,945,626 INR +86945615.15 (+801342075.1%)
Other Other diff
Total Investments
₹ 100 ₹ 10,475,432,000 INR +10475431900 (+10475431900%)
Other Other diff
Total Loans And Advances
₹ 100 ₹ 5,041,503,000 INR +5041502900 (+5041502900%)
Other Other
Total Purchases
₹ 0 ₹ 0 INR 0
Other Other diff
Total Purchases For Share Of Related Party Transactions
₹ 100 ₹ 1,518,628,223 INR +1518628123 (+1518628123%)
Other Other
Total Purchases From Trading Houses
₹ 0 ₹ 0 INR 0
Other Other diff
Total Sales
₹ 100 ₹ 2,868,951,427 INR +2868951327 (+2868951327%)
Other Other diff
Total Sales For Share Of Related Party Transactions
₹ 0 ₹ 2,868,951,427 INR +2868951427
Other Other diff
Total Sales To Dealers Or Distributors
₹ 100 ₹ 203,715,150 INR +203715050 (+203715050%)
Other Other diff
Category
Subsidiary Joint Venture -
Other Other
Channels Of Communication
Other Other -
Other Other diff
Contact # Contact Person
+91 22 2495 9595 022-67607080 -
Other Other diff
Corporate Identity Number
L24239MH1924PLC001151 L24110GJ1969PLC001590 -
Other Other diff
Cost Of Goods Or Services Procured Year
₹ 365 ₹ 137 INR -228 (-62.5%)
Other Other
Date Of End Of FY
2025-03-31 2025-03-31 -
Other Other
Date Of End Of Previous Year
2024-03-31 2024-03-31 -
Other Other
Date Of End Of Prior To Previous Year
2023-03-31 2023-03-31 -
Other Other diff
Date Of Incorporation
1924-11-13 1969-05-31 -
Other Other
Date Of Start Of FY
2024-04-01 2024-04-01 -
Other Other
Date Of Start Of Previous Year
2023-04-01 2023-04-01 -
Other Other
Date Of Start Of Prior To Previous Year
2022-04-01 2022-04-01 -
Other Other diff
Deducted And Deposited With The Authority
NA Yes -
Other Other diff
Description Of Business Activity
Manufacturing, distributing, and trading in pharmaceuticals Manufacturing and marketing of finished formulations and synthetic Active Pharmaceutical Ingredients (APIs) -
Other Other diff
Description Of Main Activity
Pharmaceuticals Manufacture of Pharmaceuticals & Medicinal Chemicals -
Other Other diff
Any Corrective Actions Taken Or Underway To Address Significant Risks Or Concerns Arising From The Assessments Of Plant And Office
Since your company is compliant, there was no corrective action suggested by an auditing or inspecting authority for FY 2024-25. Since the company is compliant, there was no corrective action suggested by any auditing / inspecting authority / official. -
Other Other diff
Improvements In Environmental And Social Impacts Due To Capex
Your Company spent 41% and 30% of its total capex expenditure on technologies for improved environmental and social impact of products and processes for FY 2024... NA -
Other Other diff
Improvements In Environmental And Social Impacts Due To RAnd D
Your Company spent 41% and 30% of its total capex expenditure on technologies for improved environmental and social impact of products and processes for FY 2024... R&D expenditure spent  in  various technologies is  towards enhancing the social and environmental impact of our products and processes. -
Other Other diff
Other Channels Of Communication
Internal communications, Employee Resource Groups Manager/ employee evaluations and surveys. Directly or through CSR implementation partners -
Other Other diff
Other Frequency Of Engagement
Regularly Frequent and need based -
Other Other diff
Highest Authority Responsible For Implementation And Oversight Of The Business Responsibility Policy
Name: Mr. Bhushan Akshikar Designation: Managing Director Director Identification Number (DIN): 09112346 Dr. Dinesh S Patel, Executive Chairman Dr. Sachin D Patel, Managing Director & CEO -
Other Other
Do Human Rights Requirements Form Part Of Your Business Agreements And Contracts
Yes Yes -
Other Other
Do The Enlisted Policies Extend To Your Value Chain Partners
Yes Yes -
Other Other
Do You Have AFocal Point Responsible For Addressing Human Rights Impacts Or Issues Caused Or Contributed To By The Business
Yes Yes -
Other Other
Do You Have APreferential Procurement Policy Where You Give Preference To Purchase From Suppliers Comprising Marginalized Or Vulnerable Groups
No No -
Other Other diff
Does Company Participate In The Business Responsibility Initiatives Of The Listed Entity
Yes No -
Other Other
Does The Entity Display Product Information On The Product Over And Above What Is Mandated As Per Local Laws
Yes Yes -
Other Other
Does The Entity Have ABusiness Continuity And Disaster Management Plan
Yes Yes -
Other Other diff
Does The Entity Have An Equal Opportunity Policy As Per The Rights Of Persons With Disabilities Act 2016
Yes No -
Other Other diff
Does The Entity Have Procedures In Place For Sustainable Sourcing
Yes No -
Other Other
Does The Entity Provide Transition Assistance Programs To Facilitate Continued Employability And The Management Of Career Endings Resulting From Retirement Or Termination Of Employment
Yes Yes -
Other Other diff
EMail Of Contact Person
in.investorquery@gsk.com pradeep.chandan@themismedicare.com -
Other Other diff
EMail
in.investorquery@gsk.com cfoassist@themismedicare.com -
Other Other
Financial Implications Of The Risk Or Opportunity
Negative Implications Negative Implications -
Other Other
Frequency Of Engagement
Others – please specify Others – please specify -
Other Other diff
From Which Marginalized Or Vulnerable Groups Do You Procure
na Not Applicable -
Other Other diff
Gross Wages Paid To Female
₹ 16.44 ₹ 45,398,124 INR +45398107.56 (+276144206.6%)
Other Other
Has The Entity Carried Out Independent Assessment Evaluation Of The Working Of Its Policies By An External Agency
No No -
Other Other
Has The Entity Conducted Life Cycle Perspective Or Assessments For Any Of Its Products Or For Its Services
No No -
Other Other
Indicate Whether Risk Or Opportunity
R R -
Other Other
Is The Entity Compliant With The Applicable Environmental Law
Yes Yes -
Other Other
Is The Premise Or Office Accessible To Differently Abled Visitors As Per The Requirements Of The Rights Of Persons With Disabilities Act 2016
Yes Yes -
Other Other diff
Material Issue Identified
Information and Cyber Security Data Integrity and Cyber Security -
Other Other
Median Of Remuneration Or Salary Or Wages Of Key Managerial Personnel
₹ 0 ₹ 0 INR 0
Other Other diff
NICCode Of Product Or Service Sold By The Entity
21,002 2,100 -18902 (-90%)
Other Other diff
NOx
14.81 mg 73.1 mg +58.29 mg (+393.6%)
Other Other diff
Name Of Contact Person
Mr. Ajay Nadkarni Mr. Pradeep M. Chandan -
Other Other
Name Of Stock Exchange Where The Company Is Listed
NSE NSE -
Other Other diff
Name
GlaxoSmithKline Pharmaceuticals Limited THEMIS MEDICARE LIMITED -
Other Other diff
Name Of The Holding Or Subsidiary Associate Companies Or Joint Ventures
Biddle Sawyer Limited Richter Themis Medicare (India) Pvt. Ltd. -
Other Other diff
Name Of The Trade And Industry Chambers Or Associations
European Federation of Pharmaceutical Industries and Associations (EFPIA) India Regulatory network Indian Pharmaceutical Association (IPA) -
Other Other diff
Net Worth
₹ 19,492,304,766 ₹ 2,873,200,000 INR -16619104766 (-85.3%)
Other Other diff
# Affiliations With Trade And Industry Chambers Or Associations
5 3 -2 (-40%)
Other Other diff
# Countries Where Market Served By The Entity
0 44 +44
Other Other diff
# Days Of Accounts Payable
P128D P1D -
Other Other diff
# Dealers Or Distributors To Whom Sales Are Made
5,706 185 -5521 (-96.8%)
Other Other diff
# Female Key Management Personnel
6 0 -6 (-100%)
Other Other diff
# Forced Recalls
1 0 -1 (-100%)
Other Other
# Key Managerial Personnel For Remuneration Or Salary Or Wages
0 0 0
Other Other
# Locations
0 0 0
Other Other
# States Where Market Served By The Entity
28 28 0 (0%)
Other Other
# Trading Houses Where Purchases Are Made
0 0 0
Other Other diff
# Voluntary Recalls
0 1 +1
Other Other diff
Particulate Matter
17.3 mg 100.6 mg +83.3 mg (+481.5%)
Other Other diff
% Capex
0.41 0 -0.41 (-100%)
Other Other
% Child Labour Of Your Plants And Offices That Were Assessed P 5
1 1 0 (0%)
Other Other
% Cost Incurred On Well Being Measures With Respect To Total Revenue
0 0 0 (-52.1%)
Other Other diff
% Directly Sourced From MSMEs Or Small Producers
0.05 0.16 +0.1 (+186.9%)
Other Other
% Discrimination At Work Place Of Your Plants And Offices That Were Assessed P 5
1 1 0 (0%)
Other Other diff
% Female Key Management Personnel
0.4 0 -0.4 (-100%)
Other Other
% Forced Labour Or Involuntary Labour Of Your Plants And Offices That Were Assessed P 5
1 1 0 (0%)
Other Other diff
% Gross Wages Paid To Female To Total Wages Paid
0.16 0.05 -0.12 (-70.6%)
Other Other diff
% Inputs Were Sourced Sustainably
1 0.5 -0.5 (-50%)
Other Other diff
% Investments In Related Parties In Total Investments
0.01 1 +0.99 (+9900%)
Other Other
% Loans And Advances Given To Related Parties In Total Loans And Advances
1 1 0 (0%)
Other Other
% Persons In Respective Category Covered By The Awareness Programmes
1 1 0 (0%)
Other Other diff
% Purchases From Related Parties In Total Purchases For Share Of Related Party Transactions
0.32 0.95 +0.63 (+198.4%)
Other Other
% RAnd D
0 0 0
Other Other diff
% Sales To Dealers Or Distributors In Total Sales
0.99 0.07 -0.92 (-92.8%)
Other Other diff
% Sales To Top Ten Dealers Or Distributors In Total Sales To Dealers Or Distributors
0.11 0.43 +0.32 (+293.4%)
Other Other diff
% Shares Held By Listed Entity
1 0.49 -0.51 (-51%)
Other Other diff
% Sourced Directly From Within The District And Neighbouring Districts
0.75 0.8 +0.05 (+6.4%)
Other Other
% Wages Of Your Plants And Offices That Were Assessed P 5
1 1 0 (0%)
Other Other diff
% Working Conditions Of Your Plants And Offices That Were Assessed P 3
0 1 +1
Other Other diff
Performance Against Above Policies And Follow Up Action Frequency
Annually Any other -
Other Other diff
Performance Against Above Policies And Follow Up Action Indicate Whether Review Was Undertaken By
Any other Committee Director -
Other Other diff
Product Or Service Sold By The Entity
Pharmaceuticals Manufacture of Pharmaceuticals & Medicinal Chemicals -
Other Other diff
Purpose And Scope Of Engagement Including Key Topics And Concerns Raised During Such Engagement
• Business outlook and performance • Career opportunities and personal development • Inclusive and diverse work environment Support through socially high impact projects -
Other Other diff
Rationale For Identifying The Risk Opportunity
Disruption to our supply chain can lead to product shortages and product recalls, regulatory intervention, reputational harm and lost sales revenue The pharmaceutical industry is highly regulated. Non compliance can result in reputational damage and financial losses. -
Other Other diff
Reach Of Trade And Industry Chambers Or Associations
International National -
Other Other diff
Reasons For Voluntary Recall
No Recall on account of Safety Issues in FY 2024-25 A voluntary recall has been initiated for a specific batch as part of our commitment to maintain our high standards of quality -
Other Other
Reporting Boundary
Standalone basis Standalone basis -
Other Other diff
Revenue From Operations
₹ 372,348,760,000 ₹ 410,811,000 INR -371937949000 (-99.9%)
Other Other diff
SOx
6.93 mg 44.1 mg +37.17 mg (+536.4%)
Other Other diff
Stakeholder Group
Employees Communities -
Other Other diff
Telephone
+91 22 24959595 022-67607080 -
Other Other diff
Total # Key Management Personnel
15 4 -11 (-73.3%)
Other Other diff
Total Revenue
₹ 100 ₹ 4,773,421,000 INR +4773420900 (+4773420900%)